menu
    • menu
    [{"orgOrder":0,"company":"University Medicine Greifswald","sponsor":"Esteve Pharmaceuticals GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"GERMANY","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Oxyphencyclimine","moa":"Muscarinic acetylcholine receptor M1 | Muscarinic acetylcholine receptor M3","graph1":"Neurology","graph2":"Phase I","graph3":"University Medicine Greifswald","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University Medicine Greifswald \/ Esteve Pharmaceuticals GmbH","highestDevelopmentStatusID":"6","companyTruncated":"University Medicine Greifswald \/ Esteve Pharmaceuticals GmbH"}]

    Find Clinical Drug Pipeline Developments & Deals for Oxyphencyclimine

    Menu

    Oxyphencyclimine

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            University Medicine Greifswald

                            Country arrow
                            Aquaexpo
                            Not Confirmed

                            University Medicine Greifswald

                            Country arrow
                            Aquaexpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Oxyphencyclimine

                            Therapeutic Area : Neurology

                            Study Phase : Phase I

                            Sponsor : Esteve Pharmaceuticals GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution

                            Details : Oxyphencyclimine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Urinary Bladder, Neurogenic.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            September 05, 2011

                            Lead Product(s) : Oxyphencyclimine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase I

                            Sponsor : Esteve Pharmaceuticals GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth